Showing results 1 to 2 of 2
Title | Author(s) | Issue Date | |
---|---|---|---|
Comparative Effectiveness and Safety Between Apixaban, Dabigatran, Edoxaban, and Rivaroxaban Among Patients With Atrial Fibrillation Journal:Annals of Internal Medicine | 2022 | ||
1-Mar-2023 |